Ionis Pharmaceuticals
IONS
IONS
359 hedge funds and large institutions have $6.17B invested in Ionis Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 123 increasing their positions, 128 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
359
Holders Change
-3
Holders Change %
-0.83%
% of All Funds
5.2%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
49
Increased
123
Reduced
128
Closed
50
Calls
$48.1M
Puts
$27.5M
Net Calls
+$20.7M
Net Calls Change
+$19M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$46.8M |
| 2 |
BlackRock
New York
|
+$31M |
| 3 |
Squarepoint
New York
|
+$29.7M |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
+$19M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$18.1M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$44.1M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$43.8M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$40M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$35.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$33.5M |
